Series B - KalVista Pharmaceuticals - Jul 22, 2015 Funding Round Profile - Cointime

Bitcoin $79,786.07 +5.00%
Ethereum $3,213.21 +6.65%
BNB $639.47 +3.69%
Optimism $1.71 +8.33%
Arbitrum $0.64 +9.33%
Solana $211.25 +7.55%
Polygon $0.41 +9.73%
Cosmos $5.44 +16.27%
Avalanche $32.75 +13.78%

Bitcoin $79,786.07 +5.00%
Ethereum $3,213.21 +6.65%
BNB $639.47 +3.69%
Optimism $1.71 +8.33%
Arbitrum $0.64 +9.33%
Solana $211.25 +7.55%
Polygon $0.41 +9.73%
Cosmos $5.44 +16.27%
Avalanche $32.75 +13.78%

KalVista Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 33M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
RA Capital Management	-	Yes	-	Detail
Longwood Fund	-	-	-	Detail
Novo Holdings	-	-	-	Detail
SV Health Investors	-	-	-	Detail
Venrock	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Aug 23, 2011	Series A	£ 8M	Novo Holdings,SV Health Investors	Detail